Tramadol And S

Medical research alone cannot change what Americans eat. I've talked to drug company reps who say selling their drugs to doctors is becoming increasingly difficult because these doctors are no longer willing to blindly accept the promises of drug companies. The pharmaceutical industry has been its own worst enemy in all of this. It used to be that prescription drugs could only be touted to physicians. These advertisements contribute to rising costs by inducing consumer demand for newer, higher-priced drugs, when the older ones may work just as well. At pharmaceutical companies, doctors usually don't make the final decisions—business people make them. More than half recognized Paxil, 45 percent knew the cholesterol-lowering Zocor, and nearly 80 percent were aware of the pharmaceutical phenomenon Viagra. And 15 to 20 percent of the APA's income in recent years has come directly from drug company advertising in APA journals—another means of guaranteeing good press for new drugs. With approximately 600,000 physicians in active practice this amounts to more than $30,000 spent on each physician. America is just as at risk now, as it was in November, as it was two years ago, and as it was five years ago. Within the Center for Drug Evaluation and Research about 80 percent of the resources are geared towards the approval of new drugs and 20 percent is for everything else.